From biotech to managed care, companies are tackling new challenges in science and business. Our healthcare roundtable experts pick 12 stocks that could win. Read More...
Reuters
U.S. rollout of new COVID boosters off to slow start
Last year, when the United States initially authorized COVID boosters just for older and immunocompromised people, nearly 10 million received their third shot in the first three weeks. The latest data, released late on Thursday by the U.S. Centers for Disease Control and Prevention (CDC), did show increased interest in the Omicron shots over demand for the older boosters during the previous three weeks. In those three weeks, about 930,000 people received booster shots of the old vaccines available to those aged 50 and older or at risk for severe disease, according to CDC data.
Add Comment